Healthcare Cell Line Development Services Market Growth | Page 3

Cell lines are essential for a wide range of applications including gene
function studies, drug discovery assays, the production of biotherapeutics
and diagnostics. The application of cell lines lies in research, bioproduction
and diagnostics. Among research, cell lines are used for studying disease,
screening, cell-based assays are used during discovery phase and preclinical
development. Cell lines are consumed to manufacture a wide range of
biotherapeutics comprising of vaccine, recombinant proteins that includes
peptides, cytokines, hormones and clotting factors, enzymes and monoclonal
antibodies.
Technological Advancements - The cell line technology is widely used in
research and biotechnology industry. Advancement in biotechnology
industry across the globe has led to development in cell culture, drug
discovery and gene therapy. Technological improvements in development,
manufacturing, screening technologies and assays possess immense growth
opportunity for the market. Government initiatives for improving healthcare
sector boosting the growth of the industry.
This report also provides the existing competitive scenario of some of the key
players of the cell line development services market which includes company
profiling of Lonza Group AG, FUJIFILM Diosynth Biotechnologies U.S.A.,
Inc., Merck KGaA, Selexis S.A., Rentschler Biopharma SE, Horizon
Discovery Group Plc., WuXi AppTec Group, Boehringer Ingelheim
International GmbH, MabPlex Inc. and Catalent, Inc..
The profiling enfolds key information of the companies which encompasses
business overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the cell
line development market that will help industry consultants, equipment